Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
The application of artificial intelligence to thyroid nodule assessment 10.1016/j.mpdhp.2024.03.004
Biomarkers for progressive multifocal leukoencephalopathy 10.1016/S1474-4422(24)00099-1
Cancer cytogenetics in a genomics world: wedding the old with the new 10.1016/j.blre.2024.101209
Changes in immune cell subtypes during ageing 10.1016/j.archger.2024.105376
Clinical and biochemical features used to classify type-1 and type-2 diabetes 10.4103/jod.jod_21_24
Clinical value of Alzheimer's disease biomarker testing 10.1002/trc2.12464
A comprehensive comparison of DNA and RNA vaccines 10.1016/j.addr.2024.115340
Comprehensive overview of analytical and bioanalytical methodologies for the opioid analgesics - tramadol and combinations 10.1016/j.ab.2024.115579
Distinguishing non-small-cell carcinoma from its histological mimics 10.1016/j.mpdhp.2024.04.004
Engineering antigen-presenting cells for immunotherapy of autoimmunity 10.1016/j.addr.2024.115329
From GWASs toward mechanistic understanding with case studies in dermatogenetics 10.1016/j.jid.2024.03.013
Gene networks and systems biology in Alzheimer's disease 10.1002/alz.13790
Genetic tools for cell lineage tracing and profiling developmental trajectories in the skin 10.1016/j.jid.2024.02.006
Genome sequencing for diagnosing rare diseases 10.1056/NEJMoa2314761
Matrix remodeling enzymes as potential fluid biomarkers of neurodegeneration in Alzheimer’s disease 10.3390/ijms25115703
Molecular probes for super-resolution imaging of drug dynamics 10.1016/j.addr.2024.115330
Multiscale engineering of brain organoids for disease modeling 10.1016/j.addr.2024.115344
Nuclear features in thyroid cytology 10.1016/j.mpdhp.2024.04.001
Painting the path to precision: unraveling endocrine tumors with immunohistochemistry 10.1016/j.mpdhp.2024.03.003
Pitfalls in the interpretation of parathyroid pathology 10.1016/j.mpdhp.2024.03.002
Protein-based biomarkers in pulmonary malignancies 10.1016/j.mpdhp.2024.04.002
Recent advancements in non-invasive wearable electrochemical biosensors for biomarker analysis 10.1016/j.ab.2024.115578
Testing for genomic biomarkers in non-small-cell lung cancer 10.1016/j.mpdhp.2024.04.003
Advanced Drug Delivery Reviews (Jul); Alzheimer’s and Dementia (May); Alzheimer’s and Dementia: Translational Research and Clinical Interventions (Apr-Jun); Analytical Biochemistry (Sep); Archives of Gerontology and Geriatrics (Jul); Blood Reviews (Jul); Diagnostic Histopathology (Jun-Jul); International Journal of Molecular Sciences (May); Journal of Diabetology (Apr-Jun); Journal of Investigative Dermatology (May-Jun); Lancet Neurology, The (May); NEJM (Jun)
Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications 10.1016/j.addr.2024.115237
Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens: a single-institution experience of 70 cases 10.1016/j.mpdhp.2024.02.002
The bisulfite reaction with cytosine and genomic DNA structure 10.1016/j.ab.2024.115532
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria 10.1016/j.addr.2024.115320
Challenges and progress related to gene editing in rare skin diseases 10.1016/j.addr.2024.115294
Clinical relevance and advances in detection of translational biomarker cardiac troponin 10.1016/j.ab.2024.115505
COVID-19 electrochemical immunosensor with Ag-MOF: rapid and high-selectivity nasal swab testing for effective detection 10.1016/j.ab.2024.115500
From cells to subcellular organelles: next-generation cancer therapy based on peptide self-assembly 10.1016/j.addr.2024.115327
Identification of volatile biomarkers for lung cancer from different histological sources: a comprehensive study 10.1016/j.ab.2024.115527
Microscopic colitis: what's in a name? An overview from clinical and histological perspectives 10.1016/j.mpdhp.2024.01.001
Molecular uropathology: what a practising pathologist should know 10.1016/j.mpdhp.2024.02.003
The morphomolecular features of cholangiocarcinoma in the personalised era 10.1016/j.mpdhp.2024.01.004
A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines 10.1016/j.addr.2024.115305
Non-viral delivery of RNA for therapeutic T cell engineering 10.1016/j.addr.2024.115215
Prolidase activity assays. A survey of the reported literature methodologies 10.1016/j.ab.2024.115506
Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases 10.1016/j.addr.2024.115323
Research progress on prediction of RNA-protein binding sites in the past five years 10.1016/j.ab.2024.115535
Testicular germ cell tumors: challenges in tumor diagnosis and pathological staging 10.1016/j.mpdhp.2024.02.004
Advanced Drug Delivery Reviews (May-Jun); Analytical Biochemistry (Jun-Aug); Diagnostic Histopathology (Apr-May)
AcousticRobots: smart acoustically powered micro-/nanoswimmers for precise biomedical applications 10.1016/j.addr.2024.115201
Antimicrobial, antioxidant, cell imaging and sensing applications of fluorescein derivatives: A review 10.1016/j.ab.2024.115479
Beyond the adverse effects of the systemic route: Exploiting nanocarriers for the topical treatment of skin cancers 10.1016/j.addr.2024.115197
Differential diagnosis of sinonasal tumours with emphasis given to undifferentiated malignancy, spindle cell lesions and tumours with divergent differentiation 10.1016/j.mpdhp.2023.12.002
Emerging strategies for nanomedicine in autoimmunity 10.1016/j.addr.2024.115194
From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research 10.1016/j.addr.2024.115199
Human stem cell-based embryo models (UK Parliamentary Office of Science and Technology research briefing, 29th February 2024)
The immunostimulatory nature of mRNA lipid nanoparticles 10.1016/j.addr.2023.115175
An insight into the state of nanotechnology-based electrochemical biosensors for PCOS detection 10.1016/j.ab.2023.115412
Invasive breast cancer reporting guidelines: ICCR, CAP, RCPath, RCPA datasets and future directions 10.1016/j.mpdhp.2023.11.001
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond 10.1016/j.addr.2024.115190
Nanoscale contrast agents: A promising tool for ultrasound imaging and therapy 10.1016/j.addr.2024.115200
An overview of B coding of breast core biopsy categorisation and management implications 10.1016/j.mpdhp.2023.11.004
Overview of the different methods for RNA preparation in COVID-19 diagnosis process during the pandemic 10.1016/j.ab.2023.115410
Revealing the clinical potential of high-resolution organoids 10.1016/j.addr.2024.115202
Review of immune checkpoint blockade and PD-L1 testing in breast cancer 10.1016/j.mpdhp.2023.12.001
Translation of cell therapies to treat autoimmune disorders 10.1016/j.addr.2023.115161
Ultrasound-responsive microbubbles and nanodroplets: A pathway to targeted drug delivery 10.1016/j.addr.2023.115178
Unlocking the mitochondria for nanomedicine-based treatments: overcoming biological barriers, improving designs, and selecting verification techniques 10.1016/j.addr.2024.115195
Advanced Drug Delivery Reviews (Feb-Apr); Analytical Biochemistry (Mar-May); Diagnostic Histopathology (Feb-Mar); Parliamentary Office of Science and Technology [POST] website (Feb)